| The role of macrophages in neuroinflammatory and neurodegenerative pathways of Alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: pathogenetic cellular … S Mammana, P Fagone, E Cavalli, MS Basile, MC Petralia, F Nicoletti, ... International journal of molecular sciences 19 (3), 831, 2018 | 149 | 2018 |
| Functional roles of matrix metalloproteinases and their inhibitors in melanoma S Napoli, C Scuderi, G Gattuso, V Di Bella, S Candido, MS Basile, M Libra, ... Cells 9 (5), 1151, 2020 | 108 | 2020 |
| The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease. FL Candido S, Lupo G, Pennisi M, Basile MS, Anfuso CD, Petralia MC, Gattuso ... Oncology Reports 42 (3), 911-922., 2019 | 87 | 2019 |
| Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer L Falzone, S Candido, R Salemi, MS Basile, A Scalisi, JA McCubrey, ... Oncotarget 7 (45), 72758, 2016 | 82 | 2016 |
| Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis S Mammana, P Bramanti, E Mazzon, E Cavalli, MS Basile, P Fagone, ... Oncotarget 9 (9), 8263, 2018 | 79 | 2018 |
| Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach K Mangano, E Mazzon, MS Basile, R Di Marco, P Bramanti, S Mammana, ... Oncotarget 9 (25), 17951, 2018 | 70 | 2018 |
| Overexpression of macrophage migration inhibitory factor and functionally‑related genes, D‑DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma M Presti, E Mazzon, MS Basile, MC Petralia, A Bramanti, G Colletti, ... Oncology Letters 16 (3), 2881-2886, 2018 | 68 | 2018 |
| The cytokine network in the pathogenesis of major depressive disorder. Close to translation? MC Petralia, E Mazzon, P Fagone, MS Basile, V Lenzo, MC Quattropani, ... Autoimmunity reviews 19 (5), 102504, 2020 | 64 | 2020 |
| The PI3K/Akt/mTOR pathway: a potential pharmacological target in COVID-19 MS Basile, E Cavalli, J McCubrey, J Hernández-Bello, JF Muñoz-Valle, ... Drug discovery today 27 (3), 848-856, 2022 | 61 | 2022 |
| Benefits of using probiotics as adjuvants in anticancer therapy S Vivarelli, L Falzone, MS Basile, D Nicolosi, C Genovese, M Libra, ... World Academy of Sciences Journal 1 (3), 125-135, 2019 | 57 | 2019 |
| Differential modulation and prognostic values of immune-escape genes in uveal melanoma MS Basile, E Mazzon, A Russo, S Mammana, A Longo, V Bonfiglio, ... PLoS One 14 (1), e0210276, 2019 | 54 | 2019 |
| Involvement of the Nrf2/HO‐1/CO axis and therapeutic intervention with the CO‐releasing molecule CORM‐A1, in a murine model of autoimmune hepatitis K Mangano, E Cavalli, S Mammana, MS Basile, R Caltabiano, A Pesce, ... Journal of Cellular Physiology 233 (5), 4156-4165, 2018 | 52 | 2018 |
| Identification of novel chemotherapeutic strategies for metastatic uveal melanoma P Fagone, R Caltabiano, A Russo, G Lupo, CD Anfuso, MS Basile, ... Scientific reports 7 (1), 44564, 2017 | 50 | 2017 |
| Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo S Paskas, E Mazzon, MS Basile, E Cavalli, Y Al-Abed, M He, S Rakocevic, ... Investigational New Drugs 37, 1014-1028, 2019 | 47 | 2019 |
| Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches MC Petralia, E Mazzon, P Fagone, MS Basile, V Lenzo, MC Quattropani, ... Journal of affective disorders 263, 15-24, 2020 | 45 | 2020 |
| Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. pathogenic effectors and novel therapeutic targets? E Cavalli, R Ciurleo, MC Petralia, P Fagone, R Bella, K Mangano, ... Molecules 25 (5), 1194, 2020 | 43 | 2020 |
| Immunobiology of uveal melanoma: state of the art and therapeutic targets MS Basile, E Mazzon, P Fagone, A Longo, A Russo, M Fallico, V Bonfiglio, ... Frontiers in Oncology 9, 1145, 2019 | 43 | 2019 |
| Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing‑remitting multiple sclerosis to natalizumab treatment P Fagone, E Mazzon, S Mammana, R Di Marco, F Spinasanta, MS Basile, ... Molecular medicine reports 20 (1), 678-684, 2019 | 42 | 2019 |
| CHI3L1 nuclear localization in monocyte derived dendritic cells M Di Rosa, D Tibullo, S Saccone, G Distefano, MS Basile, F Di Raimondo, ... Immunobiology 221 (2), 347-356, 2016 | 40 | 2016 |
| Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection E Cavalli, MC Petralia, MS Basile, A Bramanti, P Bramanti, F Nicoletti, ... International journal of molecular medicine 46 (4), 1266-1273, 2020 | 39 | 2020 |
